'Mad Money' Lightning Round: Take Bristol-Myers Over Juno
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Tuesday evening:
Abiomed (ABMD) - Get Report : "This is a little too expensive."
Harman International (HAR) : "This company got hurt by the strong dollar. The quarters have been rocky."
Juno Therapeutics (JUNO) : "I prefer Johnson & Johnson (JNJ) - Get Report or Bristol-Myers Squibb (BMY) - Get Report ."
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.